Literature DB >> 33120733

Vici syndrome with pathogenic homozygous EPG5 gene mutation: A case report and literature review.

Kamal T Abidi1, Naglaa M Kamal2, Ayman A Bakkar3, Saad Almarri4, Rehab Abdullah5, Maram Alsufyani5, Arwa Alharbi6.   

Abstract

RATIONALE: Vici syndrome (VICIS) is a rare, autosomal recessive neurodevelopmental disorder with multisystem involvement characterized by agenesis of the corpus callosum, congenital cataracts, cardiomyopathy, combined immunodeficiency, significant developmental delay, and hypopigmentation and in some cases loss of hearing. It is caused by mutations in Ectopic P-granules protein 5 gene, which is responsible for regulating autophagy activity. PATIENT CONCERN: We report a 6-month-old Saudi female patient who was the second-born baby of first cousins. She was born by normal spontaneous vertex vaginal delivery. Parents noticed that she had global developmental delay and recurrent hospital admissions due to chest infections. DIAGNOSIS: Brain magnetic resonance imaging showed brain atrophy with corpus callosum agenesis. Ophthalmology examination revealed bilateral congenital cataract. Molecular genetic testing identified the pathogenic homozygous variant c.4751T>A p. (Leu1584*) on exon 27 of the EPG5 gene and confirmed the diagnosis of Vici syndrome.
INTERVENTIONS: Supportive multidisciplinary care plan was initiated to this untreatable syndrome. OUTCOMES: The patient died at the age of 6 months due to sepsis with uncompensated septic shock. LESSONS: VICIS is a rare untreatable disorder with worldwide distribution. High index of suspicion is needed to diagnose it and family genetic counselling is crucial.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33120733      PMCID: PMC7581136          DOI: 10.1097/MD.0000000000022302

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


Introduction

VICIS is one of the rare autosomal recessive disorders, belonging to the group of congenital disorders of autophagy. Individuals born with this disorder inherit 2 copies of the defective gene on the same autosome, one from each parent. The prevalence of VICIS is less than 1/1,000,000 worldwide. Disease onset can start since antenatal or neonatal age and the age at death can range from stillbirth to infantile, early or late childhood.[ Byrne et al[ identified 30 families with members that have VICIS. Of these, 2 families were from Saudi Arabia, 2 were from United Arab Emirates, 2 were Israeli-Arabs, one was Egyptian, and one was Omani. The exact pathophysiological mechanism underlying VICIS is yet to be understood. The syndrome presents with a wide range of presentations involving multiple systems[ and is caused by a mutation in ectopic P-granules protein 5 gene (EPG5) in chromosome 18.[ The EPG5 protein is responsible for regulating autophagy activity, a pivotal mechanism for the development and proper functioning of body organs. The first 2 cases were described by Vici and his colleagues in 1988. Vici was an Italian physician who reported 2 siblings with a set of clinical features comprising agenesis of the corpus callosum, cutaneous hypopigmentation, bilateral cataract, cleft lip and palate, and combined immunodeficiency.[ Since that original description of the disorder, an increasing number of cases have been reported with almost 78 confirmed cases published to the date.[ The patients have presented, mostly in infancy, with characteristic features of VICIS together with other phenotypic features such as progressive failure to thrive, microcephaly, nystagmus, dysmorphic features, cardiomyopathy, hypotonia, recurrent pulmonary infections, and variable immunodeficiency, among others.[ In this report, we describe a 6-month-old Saudi female infant diagnosed with VICIS features and global developmental delay who was proved genetically.

Case description

JA was a 6-month-old female patient who was the second baby of a consanguineous parents. Her elder sibling is apparently healthy 5-years-old girl. JA was born by normal spontaneous vaginal delivery after full term pregnancy and her birth weight was 3 kg. Her mother had gestational diabetes mellitus and she was on diabetic diet plan. No history of neonatal intensive care unit admission. Although parents were well educated with some physicians being family members and despite, they noticed that their baby is not developing normal and is being hypotonic, but they denied this fact until the age of 4 months. At the age of 4 months, their baby started to have respiratory distress with desaturation and was admitted as a case of acute bronchiolitis. Her assessment revealed; global developmental delay, hypotonia with head lag, microcephaly and micrognathia. There was no associated hypopigmented skin or hair. Her abdominal examination was normal with normal female external genitalia. During hospital stay, the patient was noticed to have weak sucking and swallowing with recurrent chocking. Gastroesophageal reflux disease was investigated with no abnormalities. On the 8th day of hospitalization, the patient developed frequent tonic-clonic seizures with up rolling of both the eyes. Her electroencephalography revealed an abnormal focal epileptic discharge and levetiracetam was started. Her routine laboratory investigations were normal, and her immunological work up revealed normal immunoglobulin level. Ophthalmological examination revealed bilateral congenital cataract. Brain magnetic resonance imaging showed brain atrophy with corpus callosum agenesis (Fig. 1) and poor grey and white matter differentiation with a scarce myelin sheath. Her echocardiography showed hypertrophic cardiomyopathy with mitral regurgitation, tricuspid regurgitation, and pulmonary hypertension (Fig. 2 ). Chromosomal studies revealed a normal karyotype (46XX).
Figure 1

Brain Magnetic resonance imaging showing corpus callosum agenesis.

Figure 2

Echocardiography of the patient showing hypertrophic cardiomyopathy with mitral regurgitation, tricuspid regurgitation, and pulmonary hypertension.

Brain Magnetic resonance imaging showing corpus callosum agenesis. Echocardiography of the patient showing hypertrophic cardiomyopathy with mitral regurgitation, tricuspid regurgitation, and pulmonary hypertension. Echocardiography of the patient showing hypertrophic cardiomyopathy with mitral regurgitation, tricuspid regurgitation, and pulmonary hypertension. Based on the constellation of findings in the history, physical examination and investigations; the diagnosis of VICIS was suspected. Molecular genetic testing with whole exon sequencing identified the pathogenic homozygous variant c.4751T>A p. (Leu1584∗) on exon 27 of the EPG5 gene and confirmed the diagnosis (Fig. 3).
Figure 2 (Continued)

Echocardiography of the patient showing hypertrophic cardiomyopathy with mitral regurgitation, tricuspid regurgitation, and pulmonary hypertension.

Whole exome sequencing of the patient. Genetic counseling for the patients parents was carried out and the family was tested to the detected mutation which identified that both parents are heterozygous and that her sister was normal. Parents were advised for pre-conception counseling and to consider in vitro fertilization treatment. The patients terminal event was at the age of 9 months when she presented to the emergency room in critical condition and was shifted to the pediatric intensive care unit as a case of refractory septic shock with cardiac failure. Resuscitative measures were done but the patient did not revive and declared dead.

Discussion and conclusions

The infant reported here was the 3rd case reported VICIS from Saudi Arabia. Since the discovery of VICIS in 1988, a total of 79 cases including our patient have been reported. We summarized all the common features that have been associated with all patients reported with VICIS to the date in Table 1.
Table 1

Common clinical features of 78 cases of Vici syndrome.

Common clinical features of 78 cases of Vici syndrome. Most of the reported cases were associated with recurrent infections (98.73%), agenesis of corpus callosum (97.4%), developmental delay (97.4%), skin involvement (94.9%), immunodeficiency (75.94%), cataract (63.2%), and cardiomyopathy (65.8%) with the hypertrophic type being the most commonly reported. Our findings support those published in a review of 38 cases[ of VICIS where agenesis of corpus callosum, profound developmental delay, and immune problems were the most common shared features. Congenital cataract either unilateral or bilateral is considered as one of the classical diagnostic features of VICI syndrome. Other ocular manifestations such as optic neuropathy, nystagmus, and mild ptosis have been reported. In our case, the patient had a bilateral congenital cataract. Besides clinical assessment, there are many investigations to help shorten the list of differential diagnoses and assess the extent of organ involvement.[ For imaging, a brain Magnetic resonance imaging is essential to detect agenesis of corpus callosum and other less specific neuroradiological abnormalities that have been reported, such as vermis and pons hypoplasia.[ Chest X-ray and echocardiography are useful to detect lung and cardiac involvement, respectively. Abdominal ultrasonography helps to confirm laboratory findings, whether abdominal organs are affected or not. To confirm the diagnosis, molecular genetic testing should be performed to identify the homogenous or compound heterogenous mutated EPG5. Other useful tests for VICIS cases are ophthalmologic tests and ElectroencephalographyM, especially if seizures are present. Our patient underwent all these investigations. The main causes of death among cases in the first or second year of life are heart failure and sepsis. Survival analysis shows that patients with VICIS have a median survival time period of 24 months (95% confidence interval, 0–39 months).[ Thus, therapeutic interventions for VICIS are mainly supportive and directed to relieve the symptoms and to improve the survival time. Similarly, the most common causes of death among all reported patients with VICIS were recurrent infections and cardiomyopathy. Cardiac functions can deteriorate from the baseline into a heart failure in a short period of time, as shown for our patient. Therefore, patients with VICIS need to be monitored regularly for early detection of their VICIS-related complications, thus allowing timely intervention for a better outcome and prolonged survival. In conclusion, VICIS should be considered in those children with multi-systemic involvement including central nervous system, cardiovascular system and developmental delay especially in Saudi Arabia due to high consanguineous marriages rates.

Author contributions

KA: set the idea of the study and designed the study. KA, NK, AB, MA, AA: reviewed literature, drafted the manuscript, critically analyzed the data. All authors reviewed and approved the manuscript for final publication.
  22 in total

Review 1.  Muscle pathology in Vici syndrome-A case study with a novel mutation in EPG5 and a summary of the literature.

Authors:  Carola Hedberg-Oldfors; Niklas Darin; Anders Oldfors
Journal:  Neuromuscul Disord       Date:  2017-05-08       Impact factor: 4.296

2.  Severe Central Sleep Apnea in Vici Syndrome.

Authors:  Karim El-Kersh; Heinz Jungbluth; Paul Gringras; Egambaram Senthilvel
Journal:  Pediatrics       Date:  2015-10-19       Impact factor: 7.124

Review 3.  Vici syndrome in siblings born to consanguineous parents.

Authors:  Sener Tasdemir; Ibrahim Sahin; Atilla Cayır; Ihsan Yuce; Serdar Ceylaner; Abdulgani Tatar
Journal:  Am J Med Genet A       Date:  2015-09-23       Impact factor: 2.802

4.  Agenesis of the corpus callosum, combined immunodeficiency, bilateral cataract, and hypopigmentation in two brothers.

Authors:  C Dionisi Vici; G Sabetta; M Gambarara; F Vigevano; E Bertini; R Boldrini; S G Parisi; I Quinti; F Aiuti; M Fiorilli
Journal:  Am J Med Genet       Date:  1988-01

5.  Immunodeficiency in Vici syndrome: a heterogeneous phenotype.

Authors:  Andrea Finocchi; Giulia Angelino; Nicoletta Cantarutti; Maurizio Corbari; Elsa Bevivino; Simona Cascioli; Francesco Randisi; Enrico Bertini; Carlo Dionisi-Vici
Journal:  Am J Med Genet A       Date:  2011-09-30       Impact factor: 2.802

6.  Vici syndrome associated with sensorineural hearing loss and evidence of neuromuscular involvement on muscle biopsy.

Authors:  Verity McClelland; Thomas Cullup; Istvan Bodi; Deborah Ruddy; Anna Buj-Bello; Valerie Biancalana; J Boehm; Marc Bitoun; Owen Miller; Wajanat Jan; Esse Menson; Luis Amaya; John Trounce; Jocelyn Laporte; Shehla Mohammed; Caroline Sewry; Julian Raiman; Heinz Jungbluth
Journal:  Am J Med Genet A       Date:  2010-03       Impact factor: 2.802

Review 7.  Albinism and agenesis of the corpus callosum with profound developmental delay: Vici syndrome, evidence for autosomal recessive inheritance.

Authors:  M del Campo; B D Hall; A Aeby; M C Nassogne; A Verloes; C Roche; C Gonzalez; H Sanchez; A Garcia-Alix; F Cabanas; R M Escudero; R Hernandez; J Quero
Journal:  Am J Med Genet       Date:  1999-08-27

Review 8.  Vici syndrome associated with sensorineural hearing loss and laryngomalacia.

Authors:  Murat Ozkale; Ilknur Erol; Ayten Gümüş; Yasemin Ozkale; Füsun Alehan
Journal:  Pediatr Neurol       Date:  2012-11       Impact factor: 3.372

Review 9.  Vici syndrome: a review.

Authors:  Susan Byrne; Carlo Dionisi-Vici; Luke Smith; Mathias Gautel; Heinz Jungbluth
Journal:  Orphanet J Rare Dis       Date:  2016-02-29       Impact factor: 4.123

10.  EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy.

Authors:  Susan Byrne; Lara Jansen; Jean-Marie U-King-Im; Ata Siddiqui; Hart G W Lidov; Istvan Bodi; Luke Smith; Rachael Mein; Thomas Cullup; Carlo Dionisi-Vici; Lihadh Al-Gazali; Mohammed Al-Owain; Zandre Bruwer; Khalid Al Thihli; Rana El-Garhy; Kevin M Flanigan; Kandamurugu Manickam; Erik Zmuda; Wesley Banks; Ruth Gershoni-Baruch; Hanna Mandel; Efrat Dagan; Annick Raas-Rothschild; Hila Barash; Francis Filloux; Donnell Creel; Michael Harris; Ada Hamosh; Stefan Kölker; Darius Ebrahimi-Fakhari; Georg F Hoffmann; David Manchester; Philip J Boyer; Adnan Y Manzur; Charles Marques Lourenco; Daniela T Pilz; Arveen Kamath; Prab Prabhakar; Vamshi K Rao; R Curtis Rogers; Monique M Ryan; Natasha J Brown; Catriona A McLean; Edith Said; Ulrike Schara; Anja Stein; Caroline Sewry; Laura Travan; Frits A Wijburg; Martin Zenker; Shehla Mohammed; Manolis Fanto; Mathias Gautel; Heinz Jungbluth
Journal:  Brain       Date:  2016-03       Impact factor: 13.501

View more
  2 in total

1.  Novel EPG5 Mutation Associated with Vici Syndrome Gene.

Authors:  Frouzandeh Mahjoubi; Samira Shabani; Sogand Khakbazpour; Aylar Khaligh Akhlaghi
Journal:  Case Rep Genet       Date:  2022-07-05

2.  Vici syndrome in Israel: Clinical and molecular insights.

Authors:  Odelia Chorin; Yoel Hirsch; Rachel Rock; Liat Salzer Sheelo; Yael Goldberg; Hanna Mandel; Tova Hershkovitz; Nicole Fleischer; Lior Greenbaum; Uriel Katz; Ortal Barel; Nasrin Hamed; Bruria Ben-Zeev; Shoshana Greenberger; Nadra Nasser Samra; Michal Stern Zimmer; Annick Raas-Rothschild; Ben Pode-Shakked
Journal:  Front Genet       Date:  2022-09-20       Impact factor: 4.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.